An essential coagulation factor, tissue factor (TF), is rapidly expressed by human monocytes when exposed to a variety of agonists, such as lipopolysaccharide or tumor necrosis factor (TNF). We previously found that 1a,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) and its potent synthetic analogs downregulate TF and upregulate thrombomodulin expression on monocytic cells, counteracting the effects of TNF at the level of transcription. The human TF gene has characteristic binding sequences for activator protein-1 (AP-1) (c-Jun/c-Fos), nuclear factor-kB (NF-kB), Sp-1, and early growth response factor-1 (Egr-1). In this study, we investigated the regulatory mechanisms by which 1,25(OH) 2 
Tissue factor (TF) is a membrane-bound glycoprotein that is essential for activation of the extrinsic coagulation pathway. TF forms complexes with factor VII or activated factor VII (VIIa). These complexes activate factors IX and X, which then contribute to the generation of thrombin on the surface of both endothelial cells and monocytes. Although synthesis of TF in vascular monocytes is tightly regulated, its expression can be induced by a variety of agonists, such as lipopolysaccharide (LPS), tumor necrosis factor (TNF), phorbol ester, and oxidized low-density protein (LDL). 1 Induction of TF expression by endothelial cells and monocytes is associated with thrombotic disorders, such as disseminated intravascular coagulation (DIC), a rapidly fatal disorder in humans. Downregulation of pathological expression of TF appears to be a critical strategy to prevent and treat various thrombotic disorders. In addition to its role in coagulation, the TF-dependent signaling pathways contribute to a variety of pathophysiologic processes, including inflammation, atherosclerosis, angiogenesis, and tumor metastasis.
The promoter region of the TF gene contains two activator protein-1 (AP-1) sites, a nuclear factor-kB (NF-kB) site, and three early growth response factor-1 (Egr-1) sites, which serve as binding sites for transcription factors AP-1 (c-Jun/c-Fos), NF-kB (c-Rel/p65), and Egr-1. 1 Functional interactions between these transcription factors are required for maximal induction of TF gene transcription in monocytes by a variety of agonists, such as LPS, 2 TNF, 3 and phorbol ester. 4 TNF stimulation in various cells leads to phosphorylation of SAPK/ERK kinase (SEK), Jun N-terminal kinase (JNK), and c-Jun and this in turn enhances the AP-1 activation pathway. SEK is a protein kinase that activates JNK and functions in a stress-activated protein kinase cascade. Phosphorylated and activated JNK in turn phosphorylates and activates several transcription factors, including c-Jun at Ser 63/73, which then increases its trans-activating potential and DNA-binding activity to the AP-1 sites in the TF gene. 5 NF-kB transcription factors are present in the cytosol in an inactive state complexed with inhibitor kB (IkB) protein.
After stimulation with TNF, IkB is rapidly phosphorylated by IkB kinase (IKK), which in turn targets IkB for degradation. This signal induction then releases NF-kB (c-Rel/p65), which translocates into the nucleus and binds to target sites of responding genes. 6 p42/44 ERK (ERK1/2) is known to be activated by TNF stimulation, and one of the downstream targets of the ERK pathway is the transcription factor Elk-1. Phosphorylation of Elk-1 by the ERK pathway induces Egr-1 expression. 7 A recent study demonstrated that PI3K-Akt may play a pivotal role in cytokine-induced transcriptional activation of NF-kB-and AP-1-dependent gene expression. 8, 9 The active form of vitamin D 3 , 1a,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), influences the expression of various genes, whose products are involved in calcium homeostasis, cell differentiation, and regulation of the immune response. 10 The expression of these genes is mediated by binding to its nuclear vitamin D receptor (VDR), a transcription factor, which dimerizes with either itself or other nuclear receptors, such as the retinoid X receptor (RXR). 11, 12 We have previously found that 1,25(OH) 2 D 3 and its synthetic analogs downregulate TF and upregulate thrombomodulin (TM) expression in monocytic cells, counteracting the effects of TNF and oxidized LDL. 13, 14 Pathogenic expression of TF mRNA in monocytic cells was markedly downregulated by 1,25(OH) 2 D 3 and its synthetic analogs . Several subsequent studies have reported that the vitamin D/VDR system plays a physiological role in vivo in the maintenance of antithrombotic homeostasis. Aihara et al. 15 demonstrated that upregulation of TF and downregulation of TM in the aorta, liver, and kidney were related to enhanced thrombogenicity in VDR knockout mice. 1,25(OH) 2 D 3 was effective against DIC in a rat model induced by LPS. 16 However, the mechanism and signaling pathway of 1,25(OH) 2 D 3 that downregulate TNF-induced TF gene expression are not known. In this study, we investigated the regulatory mechanisms by which 1,25(OH) 2 D 3 inhibits TNF-induced TF gene expression in several pathways related to TF gene transcription in human monocytic cells.
MATERIALS AND METHODS Reagents 1,25(OH) 2 D 3 (Sigma, St Louis, MO, USA) was dissolved in absolute ethanol and then added to growth media at the indicated concentrations. The final ethanol concentration in the culture media was less than 0.1%. Ethanol at a concentration less than 0.1% has no effect on cell growth or differentiation of each cell line. 17 For the untreated control, the same amount of ethanol was added to the culture medium. TNF was from Roche Molecular Biochemicals (Mannheim, Germany). All other chemicals were reagent-grade products and were purchased from Wako Pure Chemicals (Osaka, Japan), unless otherwise indicated.
Cell Culture
As the anticoagulant effects of 1,25(OH) 2 D 3 have been detected in monocytic leukemia cell line U937 as well as in human peripheral monocytes, 14 we primarily used monoblastic leukemia cell line THP-1 cells and partly U937 cells in this study, both of which were provided by Health Science Research Bank. Cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum, 0.2% sodium carbonate, 2 mM glutamine, and 50 U/ml penicillin-streptomycin.
Cell Surface TF Activity A portion of the cells (2 Â 10 6 ) suspended in phosphatebuffered saline (PBS) was added to 0.1 ml of pooled human normal plasma. After incubation at 371C for 2 min, 0.1 ml of 25 mM calcium chloride was added and the plasma recalcification time was measured by a CA-100 semiautomatic coagulator (Sysmax, Kobe, Japan). The procoagulant activity associated with the surface of THP-1 cells was attributable to the occurrence of TF expression 13, 14 and thus the prolongation of the recalcfication time is mainly due to downregulation of TF expression. TF cofactor activity was quantitatively measured by reference to a standard curve constructed with human placental TF, and the amount of TF activity that yielded a 50-s recalcification time was defined as 1 U/ml.
Mobility Gel Shift Assay
The electrophoretic gel-shift assay was performed according to the manufacturer's instructions (Roche Molecular Biochemicals) for binding of nuclear proteins to digoxigenin (DIG)-labeled oligonucleotides containing AP-1 (5 0 -GG TTGAATCACTGGGGTGAGTCATCC-3 0 ), NF-kB (5 0 -TCCC GGAGTTTCCTAC-3 0 ), and Egr-1 (5 0 -GGGCCGGGGGCG GGGAGT-3 0 ) sites (underlined) of the TF promoter. The relative signal intensity of bands was determined and standardized using Scion Image Software (Scion, Frederick, MD, USA). The binding specificity of nuclear proteins to the DIGlabeled oligonucleotide was determined by competition with an excess of unlabeled oligonucleotide or the respective antibodies, anti-phopho(Ser63)-c-Jun (anti-P-c-Jun), antip65, and anti-Egr-1.
Plasmids
The following plasmids were used: p(AP-1) 4 -LUC contains two copies of two AP-1 sites (AP-1 D and AP-1 P ), 1 p(NFkB) 4 -LUC contains four copies of the NF-kB site, and p(Egr-1) 4 -LUC contains two copies of the Egr-1 site (Sp1 I and Sp1 II ). These sites were cloned upstream of the minimal simian virus SV40 promoter expressing the firefly luciferase (LUC) reporter gene in pGL3-Enhancer from Promega (Madison, WI, USA). The pRL-SV40 control vector was compared with pGL3-Enhancer vector cloned target plasmids.
Transfection THP-1 cells were transfected using DEAE-dextran Transfection Reagent (Promega) 2, 18 with p(AP-1) 4 SV40-LUC, p(NFkB) 4 SV40-LUC, and p(Egr-1) 4 SV40-LUC in each. Cells were cotransfected with a control reporter vector, pRL-SV40, which encoded Renilla (Sea Pansy luciferase), and two expression plasmids coding either human VDR or RXRa. Expression vectors for human VDR 19 and RXRa 20 cDNAs were kindly provided by Dr Umesono K and Dr Kakizuka A, respectively (Kyoto University). Dr RM Evans (Howard Hughes Medical Institute, CA, USA) generously supported the use of the cDNAs. After transfection, the THP-1 cells were preincubated with 0.1 mM 1,25(OH) 2 D 3 for 1 h before stimulating with 1 nM TNF for 5 h at 371C. Cell lysates were then assayed for LUC activity using the Dual-Luciferase Reporter Assay System (Promega), and LUC assays were sequentially analyzed in a Lumat (Berthold), as previously reported. 13 LUC activity data are expressed as means7s.d.
Immunoblotting Analysis TNF-stimulated cells (2 Â 10 6 ), at the indicated time with or without 1,25(OH) 2 D 3 , were suspended in sampling buffer, and lysed by sonication using Bioruptor (Cosmo Bio, Tokyo, Japan). The phosphorylated states of c-Jun, JNK, SEK, and IkB in cell lysates were determined according to the manufacturer's instructions (Cell Signaling Technology, Beverly, MA, USA). Phosphorylated states of ERK1/2, Elk-1, Egr-1, and Akt in cell lysates were determined according to the manufacturer's instructions (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The relative signal intensity of bands was determined and standardized using Scion Image Software.
Immunoprecipitation Assay
For immunoprecipitation experiments, cells were lysed in buffer (0.05 M Tris-HCl, 0.15 M NaCl, 1% Nonidet P-40, and 1 mM phenylmethylsulfonyl fluoride), and sequentially immunoprecipitated using an excess of anti-VDR antibody (Santa Cruz Biotechnology), and then subjected to immunoblotting analysis using anti-c-Jun antibody (Cell Signaling Technology) for detection as described previously. 21 Statistical Analysis Data were expressed as mean7s.d. Statistical analysis was performed by nonparametric Wilcoxon signed rank test for paired data. For nonparametric multiple comparisons, we performed Steel's test or the Steel-Dwass test using KyPlot 4.0 (Kyens Lab Inc., Tokyo, Japan). A P-value of 40.05 was considered to represent a statistically nonsignificant change. Gel mobility shift assay was performed using the probe. Lane 1 corresponds to the DIG-labeled probe only. To demonstrate the specificity of protein binding, cold competitor oligonucleotides containing each site or the respective antibodies against transcription factors were used. A 100-fold molar excess of cold competitor oligonucleotides containing each site were included in control samples (lane 6). The respective antibodies (100 mg/ml), anti-c-Jun, anti-p65, and anti-Egr-1, were included in TNF-treated samples (lane 7 indicated by the competitor with an asterisk). Data are representative of six independent experiments using each probe and confirmed by corrected densitometric quantification. Egr-1 was induced by phosphorylation and activation of Elk-1, and was detected after 1 h of TNF stimulation and peaked at 2 h. However, preincubation and the following coincubation with 1,25(OH) 2 D 3 did not inhibit the increase of Egr-1 (Figure 6c and d) . These results indicate that 1,25(OH) 2 D 3 has no effect on phosphorylation of MEK-ERK1/2 pathway. 
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DISCUSSION
In this study, we have shown that 1,25(OH) 2 D 3 impairs basal and TNF-induced TF expression in monocytic cells by inhibition of TF gene activation. Since the promoter region of the TF gene has characteristic sequences for the binding sites of transcription factors, we paid attention to the transcription factor sites in this study. 12 The sensitivity of the gel-shift assay and that of the LUC assay seemed to be slightly different in terms of TNF-induced TF induction or 1,25(OH) 2 D 3 -induced TF inhibition.
1,25(OH) 2 D 3 suppressed the AP-1 activation pathway by inhibiting phosphorylation of c-Jun. Phosphorylation of JNK upstream of c-Jun or SEK, which is located upstream of JNK in the signal pathway, was not inhibited. Since the biologic effects of 1,25(OH) 2 D 3 are mainly mediated by an intranuclear receptor, specifically VDR, 13 we supposed that the VDR/1,25(OH) 2 D 3 complex would block TNF-induced phosphorylation of c-Jun, which has been reported to exist in the nuclear milieu. Therefore, next we examined whether 1,25(OH) 2 D 3 could repress TF expression through the binding of activated VDR to the transcriptional activation factor AP-1 by immunoprecipitation using an anti-VDR antibody, followed by immunoblotting analysis using anti-cJun and anti-P-c-Jun antibodies. Since the c-Jun band at 43 kDa was recognized in unstimulated cells, c-Jun may constitutively bind to VDR without the ligand binding in the nuclear milieu. After stimulation with 1,25(OH) 2 D 3 , the cJun band at 43 kDa was slightly increased, which indicated that ligand-bound VDR increased binding activity with c-Jun, and consequently suppressed TF gene expression. After stimulation with TNF, the band was markedly decreased and appeared to shift upward. This shifted band may represent phosphorylated c-Jun complexed with VDR. Pretreatment with 1,25(OH) 2 D 3 before TNF stimulation prevented the shift and preserved the band at 43 kDa, as observed without TNF. In the immunoblot analysis with anti-P-c-Jun antibody after the immunoprecipitation using anti-VDR antibody, the P-c-Jun band was recognized in unstimulated cells, and was compatible with basal activation of AP-1 in THP-1 cells. After stimulation with TNF, the band was markedly increased. Pretreatment with 1,25(OH) 2 D 3 markedly decreased the P-cJun band in both unstimulated and TNF-stimulated cells. These results indicated that the 1,25(OH) 2 D 3 /VDR complex inhibited the induction of c-Jun phosphorylation and TF induction by TNF stimulation through forming complexes with c-Jun, which suggests a potential direct protein-protein interaction between VDR and c-Jun. A similar inhibitory mechanism with a nuclear receptor was reported in negative regulation of AP-1 responsive genes by retinoic acid and the retinoic acid receptor a complex. 22 Activation of NF-kB has long been thought to be controlled mainly by binding of NF-kB to an inhibitor protein, IkB, which keeps the transcription factor complex in an inactive form in the cytoplasm.
23 PI3K-Akt may also play a pivotal role in TNF-induced NF-kB activation. PI3K-Akt may also cooperate with other TNF-inducible signals to activate NF-kB in HepG2 cells and U937 cells. 9 On the other hand, LPS activation of PI3K-Akt negatively regulates IKK and glycogen synthase kinase-3b, which reduce the transactivational activity of p65 in THP-1 cells. 24 Suppression of the NF-kB activation pathway by 1,25(OH) 2 D 3 was not explained by inhibition of phosphorylation of the IKK-and PI3K-Akt-pathways, as TNF-induced phosphorylation of IkB and Akt was not influenced by 1,25(OH) 2 D 3 treatment. Sandur et al demonstrated that plumbagin suppressed NF-kB activation by directly interfering with the binding of NF-kB to DNA. 25 These results indicate that suppression of the NFkB activation pathway by 1,25(OH) 2 D 3 is induced by direct inhibition of the binding activity of NF-kB transcription factors in the promoter region of the TF gene, without suppressing phosphorylation of the NF-kB activation pathway. A mechanism for the direct inhibition is not yet known, as direct binding between VDR and c-Rel/p65 has not been documented (data not shown). Additional mechanisms controlling NF-kB activation may exist in distinct cell types. 1,25(OH) 2 D 3 may upregulate expression of another factor(s), which then contributes to the impaired NF-kB translocation to the nucleus and the inhibition of NF-kB binding. 26, 27 The inhibition of the NF-kB pathway may be related to the modulation of the immune system and the differentiation of leukemia cells by 1,25(OH) 2 D 3 . Further studies are necessary to elucidate the intricate pathways that NF-kB and AP-1 play in TF gene expression. 14 We used 0.1 mM of 1,25(OH) 2 D 3 in this study to reveal the effect on TF expression. The more potent 1,25(OH) 2 D 3 analogs, which have far stronger binding affinity to VDR and which lack an adverse effect of hypercalcemia, have been synthesized.
14 Such potent analogs may serve as agents for preventing and treating cytokinemediated thrombotic diseases.
In conclusion, the present study demonstrated that 1,25(OH) 2 
